Pain Therapeutics, Inc.  

(Public, NASDAQ:PTIE)   Watch this stock  
Find more results for pain
+0.01 (0.52%)
Nov 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.93 - 1.99
52 week 1.53 - 3.65
Open 1.93
Vol / Avg. 8,328.00/77,764.00
Mkt cap 88.77M
P/E     -
Div/yield     -
EPS -0.26
Shares 45.76M
Beta 1.09
Inst. own 52%
Feb 15, 2016
Q4 2015 Pain Therapeutics Inc Earnings Release (Estimated) Add to calendar
Nov 9, 2015
Q3 2015 Pain Therapeutics Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -40.12% -27.22%
Return on average equity -42.67% -28.04%
Employees 9 -
CDP Score - -


7801 N Capital of Texas Hwy Ste 260
AUSTIN, TX 78731-1192
United States - Map
+1-512-5012444 (Phone)
+1-512-6140414 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Pain Therapeutics, Inc. is a biopharmaceutical company that develops drugs. The Company’s lead drug candidate, REMOXY, is an extended-release oral formulation of oxycodone for the management of moderate-to-severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. REMOXY is a controlled-release oral capsule form of oxycodone in a viscous liquid formulation matrix that includes excipients. REMOXY’s capsule dosage form provides therapeutic drug levels of oxycodone on a twice-daily dosing schedule, while resisting the increases in plasma levels of oxycodone associated with certain common methods of abuse and misuse. The Company’s drug candidate FENROCK is an abuse-deterrent transdermal pain patch in the pre-Investigational New Drug-stage of development.

Officers and directors

Remi Barbier Chairman of the Board, President, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Peter S. Roddy Chief Financial Officer, Vice President
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Nadav Friedmann Chief Medical and Operating Officer, Director
Age: 72
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Marsman Pharm.D Senior Vice President - Regulatory Affairs
Bio & Compensation  - Reuters
Michael J. O' Donnell Esq. Secretary, Independent Director
Age: 56
Bio & Compensation  - Reuters
Robert Z. Gussin Ph.D. Independent Director
Age: 77
Bio & Compensation  - Reuters
Saira Ramasastry Independent Director
Age: 39
Bio & Compensation  - Reuters
Sanford R. Robertson Independent Director
Age: 83
Bio & Compensation  - Reuters
Patrick J. Scannon M.D., Ph.D. Independent Director
Age: 67
Bio & Compensation  - Reuters